Q32 Bio Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Q32 Bio Inc. (FIXX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $51.80 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-03-11
- Q32 Bio Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $51.80M.
- Q32 Bio Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $38.40M, a 18.64% decline from fiscal 2020.
- Q32 Bio Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $47.20M, a 17.41% increase from fiscal 2019.
- Q32 Bio Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was $40.20M, a 60.16% increase from fiscal 2018.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2024-12-31 | $51.80M 10-K · filed 2025-03-11 |
| 2021-12-31 | $38.40M 10-K · filed 2022-03-23 |
| 2020-12-31 | $47.20M 10-K · filed 2022-03-23 |
| 2019-12-31 | $40.20M 10-K · filed 2021-03-11 |
| 2018-12-31 | $25.10M 10-K · filed 2020-03-12 |
| 2017-12-31 | $7.70M 10-K · filed 2019-03-12 |